2004/034 NICE issues guidance on use of clopidogrel for acute coronary syndrome
The National Institute for Clinical Excellence (NICE) has issued guidance to the NHS in England and Wales on the use of clopidogrel for the treatment of non-ST-segment-elevation acute coronary syndrome (ACS). Clopidogrel is an anti-clotting drug which is licensed for use in combination with aspirin for the treatment of individuals suffering from unstable angina or non-ST-segment-elevation (NSTEMI) ACS. The guidance recommends that clopidogrel, together with low does aspirin, should be used for people with non-ST-segment-elevation ACS who have a moderate to high risk of a major heart attack or death.
|2004/034 NICE issues guidance on use of clopidogrel for acute coronary syndrome
28 July 2004
(82.6Kb 29sec @ 28.8Kbps)
This page was last updated: 16 September 2011